Emily Leproust, Twist Bioscience founder and CEO
November 16, 2022 11:03 AM EST
People
Financing

Scor­pi­on Cap­i­tal goes af­ter Twist Bio­science as lat­est syn­bio tar­get, com­par­ing biotech to Ther­a­nos

Paul Schloesser

Associate Editor

The in­fa­mous short sell­er who went af­ter Gink­go Bioworks last year has a new tar­get in its sights.

Scor­pi­on Cap­i­tal re­leased a 236-page re­port Tues­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

As­traZeneca culls Phase 2 opi­oid use dis­or­der drug

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times